Latest News

DRC Director's Report - December 2022

We recently announced the results of the Fraternal Order of Eagles Diabetes Research Center twelfth round of pilot and feasibility research grants. These grant awards fund innovative pilot projects by early career investigators who are entering the diabetes research field, or established investigators with innovative ideas that focus on a new direction in diabetes research. 

The goal of the program is to generate data that will enable awardees to compete for peer-reviewed national funding for projects that show exceptional promise. A total of 13 researchers from across the University of Iowa campus submitted meritorious proposals that underwent a comprehensive and competitive review.

DRC Director's Update - November 2022

Neuropathy is a devastating diabetes complication that causes nerve damage throughout the body. This can lead to infection and/or amputation of the affected area. The most common type of neuropathy is peripheral neuropathy. This affects the nerves in the hands, feet, legs, and arms. Peripheral neuropathy is the most common complication of diabetes affecting about 50% of patients.

DRC Director's Report - November 2020

FOE Diabetes Research Center scientists from the University of Iowa have discovered a safe new way to manage blood sugar non-invasively. Exposing diabetic mice to a combination of static electric and magnetic fields for a few hours per day normalizes two major hallmarks of type 2 diabetes, namely reducing blood glucose levels and preventing insulin resistance. These new findings were published Oct. 6 in Cell Metabolism.

Eagles, Iowa Formalize Bridge To The Cure Project

On Tuesday, October 30, The Fraternal Order of Eagles (F.O.E.) Board of Grand Trustees met with leadership from the University of Iowa to formalize the F.O.E.'s Bridge to the Cure project, which aims to translate research projects at the F.O.E. Diabetes Research Center into new medications to help alleviate the effects of diabetes.

With the new agreement, the F.O.E. Diabetes Research Center staff, led by Director Dr. E. Dale Abel, will form a committee, including one Eagles member, to recommend research projects for trial drug testing. Once a recommendation is made, it will be passed along to the F.O.E.'s Board of Grand Trustees, who will determine whether or not to issue a grant from the F.O.E. Diabetes Research Center Fund to facilitate the trials.